|
|
|
|
| Advertisement |
 |
|
|
| Investing in Drug Development |
|
|
Impact Investing and R&D |
Private equity investment and venture capital have long spurred R&D efforts for hard-to-treat conditions. Joining the mix of late has been impact investing and the opportunities for the socially-conscious to influence drug development–and reap potential benefits in health outcomes and financial return.
... /Read more/ |
|
|
| Advertisement |
 |
Deloitte's 2019 Life Sciences accounting and financial reporting update
Insights on new accounting standards and more
A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment.
 Download the full report here
|
|
|
ADVERTISEMENT
|
|
| Advertisement |
 |
|
|
| Advertisement |
Exclusive Interview from eyeforpharma:
Knowledge, Data, Trust: Supporting the HCP-Pharma Ecosystem
 Watch Now
|
|
| Finance |
|
|
Dollars and Digital: The Future of Pharma Finance
|
In this roundtable, pharma and biotech finance leaders discuss the pace of digital technology adoption in accounting and reporting, and the growing recognition of data and analytics in delivering deeper business insights across the organization.
... /Read more/ |
|
|
| Advertisement |
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
On Demand
 Learn More
|
|
| Ruling in Favor of Biotech |
 |
|
The Pharm Exec Podcast: Episode 31 |
Editor-in-Chief Lisa Henderson speaks with Bill Newell, CEO of Sutro Biopharma about his background in corporate law and how it helps him in his role as a biotech executive, the importance of collaboration between big pharma and biotech, a story about keeping the San Francisco Giants in the Bay area, and other analogies around sports related to running a biotech.
... /Read more/ |
|
|
|
ADVERTISEMENT
|
|
|
|
|
